Safety and efficacy of combinatorial therapy utilizing myeloablative conditioning and autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults with relapsed/refractory mature B-cell non-Hodgkin lymphoma Research Letter
| Authors: | Gardenswartz, A.; Mehta, B.; El-Mallawany, N. K.; van de Ven, C.; Hochberg, J.; Flower, A.; Morris, E.; Harrison, L.; Chu, Y.; Basso, J.; Gerard, P.; Islam, H.; Ayello, J.; Baxter-Lowe, L. A.; Cairo, M. S. |
| Title: | Safety and efficacy of combinatorial therapy utilizing myeloablative conditioning and autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults with relapsed/refractory mature B-cell non-Hodgkin lymphoma |
| Keywords: | adolescent; adult; child; event free survival; young adult; busulfan; fludarabine; allogeneic stem cell transplantation; drug tolerability; cancer recurrence; drug safety; ibritumomab tiuxetan; rituximab; letter; carboplatin; multiple cycle treatment; thrombocyte; neoplasm recurrence, local; etoposide; incidence; cyclophosphamide; autologous stem cell transplantation; stem cell transplantation; hematopoietic stem cell transplantation; carmustine; ifosfamide; risk assessment; chronic graft versus host disease; engraftment; myeloablative conditioning; nonhodgkin lymphoma; neutrophil; immunotherapy; lymphoma, non-hodgkin; tumor recurrence; prophylaxis; reduced intensity conditioning; transplantation conditioning; umbilical cord blood; therapy effect; large cell lymphoma; mesna; radioimmunotherapy; transplantation, autologous; graft recipient; pre b lymphocyte; thymocyte antibody; hla system; immune reconstitution; adverse event; autotransplantation; yttrium 90; refractory disease; graft versus lymphoma effect; humans; human; obinutuzumab; sargramostim; matched unrelated donor; matched sibling donor |
| Journal Title: | Leukemia and Lymphoma |
| Volume: | 64 |
| Issue: | 1 |
| ISSN: | 1042-8194 |
| Publisher: | Taylor & Francis Group |
| Date Published: | 2023-01-01 |
| Start Page: | 234 |
| End Page: | 237 |
| Language: | English |
| DOI: | 10.1080/10428194.2022.2133542 |
| PUBMED: | 36260003 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Letter -- Export Date: 1 March 2023 -- Source: Scopus |
